Telemedical support for prehospital emergency medical service in severe emergencies: an open-label randomised non-inferiority clinical trial

被引:6
|
作者
Kowark, Ana [1 ,2 ]
Felzen, Marc [1 ]
Ziemann, Sebastian [1 ]
Wied, Stephanie [3 ]
Czaplik, Michael [1 ]
Beckers, Stefan K. [1 ]
Brokmann, Jorg C. [4 ]
Hilgers, Ralf-Dieter [3 ]
Rossaint, Rolf [1 ]
机构
[1] Univ Hosp RWTH Aachen, Med Fac, Dept Anaesthesiol, Aachen, Germany
[2] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany
[3] Univ Hosp RWTH Aachen, Med Fac, Dept Med Stat, Aachen, Germany
[4] Univ Hosp RWTH Aachen, Med Fac, Emergency Dept, Aachen, Germany
关键词
Adverse events in pre-hospital emergencies; Emergency medical service; Remote emergency physician; Tele-emergency medical service; Telemedicine; STROKE; CARE;
D O I
10.1186/s13054-023-04545-z
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundA tele-emergency medical service with a remote emergency physician for severe prehospital emergencies may overcome the increasing number of emergency calls and shortage of emergency medical service providers. We analysed whether routine use of a tele-emergency medical service is non-inferior to a conventional physician-based one in the occurrence of intervention-related adverse events.MethodsThis open-label, randomised, controlled, parallel-group, non-inferiority trial included all routine severe emergency patients aged & GE; 18 years within the ground-based ambulance service of Aachen, Germany. Patients were randomised in a 1:1 allocation ratio to receive either tele-emergency medical service (n = 1764) or conventional physician-based emergency medical service (n = 1767). The primary outcome was the occurrence of intervention-related adverse events with suspected causality to the group assignment. The trial was registered with ClinicalTrials.gov (NCT02617875) on 30 November 2015 and is reported in accordance with the CONSORT statement for non-inferiority trials.ResultsAmong 3531 randomised patients, 3220 were included in the primary analysis (mean age, 61.3 years; 53.8% female); 1676 were randomised to the conventional physician-based emergency medical service (control) group and 1544 to the tele-emergency medical service group. A physician was not deemed necessary in 108 of 1676 cases (6.4%) and 893 of 1544 cases (57.8%) in the control and tele-emergency medical service groups, respectively. The primary endpoint occurred only once in the tele-emergency medical service group. The Newcombe hybrid score method confirmed the non-inferiority of the tele-emergency medical service, as the non-inferiority margin of - 0.015 was not covered by the 97.5% confidence interval of - 0.0046 to 0.0025.ConclusionsAmong severe emergency cases, tele-emergency medical service was non-inferior to conventional physician-based emergency medical service in terms of the occurrence of adverse events.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] MANAGEMENT OF SLEEP APNEA PATIENTS BY A CLINICAL NURSE: A RANDOMIZED OPEN-LABEL NON-INFERIORITY STUDY.
    Lajoie, Annie C.
    Prive, Alexis
    Roy-Halle, Annie
    Series, Frederic
    SLEEP, 2019, 42
  • [32] Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
    Tamai, Hiroya
    Ikeda, Kei
    Miyamoto, Toshiaki
    Taguchi, Hiroaki
    Kuo, Chang-Fu
    Shin, Kichul
    Hirata, Shintaro
    Okano, Yutaka
    Sato, Shinji
    Yasuoka, Hidekata
    Kuwana, Masataka
    Ishii, Tomonori
    Kameda, Hideto
    Kojima, Toshihisa
    Taninaga, Takehiro
    Mori, Masahiko
    Miyagishi, Hideaki
    Sato, Yasunori
    Tsai, Wen-Chan
    Takeuchi, Tsutomu
    Kaneko, Yuko
    LANCET RHEUMATOLOGY, 2023, 5 (04): : 215 - 224
  • [33] Dihydroartemisinin-piperaquine versus artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana: an open-label, randomised, non-inferiority trial
    Osarfo, Joseph
    Tagbor, Harry
    Cairns, Matthew
    Alifrangis, Michael
    Magnussen, Pascal
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 (08) : 1043 - 1052
  • [34] Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
    Cochereau, D.
    Lecuru, F.
    ONCOLOGIE, 2015, 17 (11-12) : 595 - 596
  • [35] Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial
    Bernard, Louis
    Dinh, Aurelien
    Ghout, Idir
    Simo, David
    Zeller, Valerie
    Issartel, Bertrand
    Le Moing, Vincent
    Belmatoug, Nadia
    Lesprit, Philippe
    Bru, Jean-Pierre
    Therby, Audrey
    Bouhour, Damien
    Denes, Eric
    Debard, Alexa
    Chirouze, Catherine
    Fevre, Karine
    Dupon, Michel
    Aegerter, Philippe
    Mulleman, Denis
    LANCET, 2015, 385 (9971): : 875 - 882
  • [36] Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
    Kehoe, Sean
    Hook, Jane
    Nankivell, Matthew
    Jayson, Gordon C.
    Kitchener, Henry
    Lopes, Tito
    Luesley, David
    Perren, Timothy
    Bannoo, Selina
    Mascarenhas, Monica
    Dobbs, Stephen
    Essapen, Sharadah
    Twigg, Jeremy
    Herod, Jonathan
    McCluggage, Glenn
    Parmar, Mahesh
    Swart, Ann-Marie
    LANCET, 2015, 386 (9990): : 249 - 257
  • [37] Outpatient elective induction of labour at 39 weeks' gestation (HOME INDUCTION): an open-label, randomised, controlled, phase III, non-inferiority trial
    Nicholson, Sarah M.
    Flood, Karen
    Dicker, Patrick
    Molphy, Zara E.
    Smith, Orla T.
    Oprescu, Corina I.
    Wall, Eimear M.
    Nimr, Sara N. El
    Shanahan, Ita M.
    Kennedy, Bernard J.
    V. Daly, Ronan
    Gannon, Geraldine
    Looi, Claudia
    Fernandez, Elena
    Malone, Fergal D.
    ECLINICALMEDICINE, 2024, 74
  • [38] Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label blinded-outcome, randomised non-inferiority trial
    Fischer, Urs
    Kaesmacher, Johannes
    Strbian, Daniel
    Eker, Omer
    Cognard, Christoph
    Plattner, Patricia S.
    Butikofer, Lukas
    Mordasini, Pasquale
    Deppeler, Sandro
    Pereira, Vitor M.
    Albucher, Jean Francois
    Darcourt, Jean
    Bourcier, Romain
    Benoit, Guillon
    Papagiannaki, Chrysanthi
    Ozkul-Wermester, Ozlem
    Sibolt, Gerli
    Tiainen, Marjaana
    Gory, Benjamin
    Richard, Sebastien
    Liman, Jan
    Ernst, Marielle Sophie
    Boulanger, Marion
    Barbier, Charlotte
    Mechtouff, Laura
    Zhang, Liqun
    Marnat, Gaultier
    Sibon, Igor
    Nikoubashman, Omid
    Reich, Arno
    Consoli, Arturo
    Lapergue, Bertrand
    Ribo, Marc
    Tomasello, Alejandro
    Saleme, Suzana
    Macian, Francisco
    Moulin, Solne
    Pagano, Paolo
    Saliou, Guillaume
    Carrera, Emmanuel
    Janot, Kevin
    Hernandez-Perez, Maria
    Pop, Raoul
    Della Schiava, Lucie
    Luft, Andreas R.
    Piotin, Michel
    Gentric, Jean Christophe
    Pikula, Aleksandra
    Pfeilschifter, Waltraud
    Arnold, Marcel
    LANCET, 2022, 400 (10346): : 104 - 115
  • [39] Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial
    Jeger, Raban V.
    Farah, Ahmed
    Ohlow, Marc-Alexander
    Mangner, Norman
    Moebius-Winkler, Sven
    Leibundgut, Gregor
    Weilenmann, Daniel
    Woehrle, Jochen
    Richter, Stefan
    Schreiber, Matthias
    Mahfoud, Felix
    Linke, Axel
    Stephan, Frank-Peter
    Mueller, Christian
    Rickenbacher, Peter
    Coslovsky, Michael
    Gilgen, Nicole
    Osswald, Stefan
    Kaiser, Christoph
    Scheller, Bruno
    LANCET, 2018, 392 (10150): : 849 - 856
  • [40] Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
    Sundar, Shyam
    Sinha, Prabhat Kumar
    Rai, Madhukar
    Verma, Deepak Kumar
    Nawin, Kumar
    Alam, Shanawwaj
    Chakravarty, Jaya
    Vaillant, Michel
    Verma, Neena
    Pandey, Krishna
    Kumari, Poonam
    Lal, Chandra Shekhar
    Arora, Rakesh
    Sharma, Bhawna
    Ellis, Sally
    Strub-Wourgaft, Nathalie
    Balasegaram, Manica
    Olliaro, Piero
    Das, Pradeep
    Modabber, Farrokh
    LANCET, 2011, 377 (9764): : 477 - 486